Shantanu Balkundi, Ph.D.
Affiliations: | 2009 | Louisiana Tech University, Ruston, LA, United States |
Area:
cellular imaging, lipid messengers, cell signaling, nanotechnologyGoogle:
"Shantanu Balkundi"Mean distance: 26716.5
Parents
Sign in to add mentor| Mark A. DeCoster | grad student | 2009 | Louisiana Tech University | |
| (Micro, nano encapsulation methods for sustained release drug formulations and biomimetic applications.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Puligujja P, Balkundi SS, Kendrick LM, et al. (2015) Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations. Biomaterials. 41: 141-50 |
| Gautam N, Puligujja P, Balkundi S, et al. (2014) Pharmacokinetics, biodistribution, and toxicity of folic acid-coated antiretroviral nanoformulations. Antimicrobial Agents and Chemotherapy. 58: 7510-9 |
| Puligujja P, McMillan J, Kendrick L, et al. (2013) Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infections. Nanomedicine : Nanotechnology, Biology, and Medicine. 9: 1263-73 |
| Gautam N, Roy U, Balkundi S, et al. (2013) Preclinical pharmacokinetics and tissue distribution of long-acting nanoformulated antiretroviral therapy. Antimicrobial Agents and Chemotherapy. 57: 3110-20 |
| Dash PK, Gendelman HE, Roy U, et al. (2012) Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice. Aids (London, England). 26: 2135-44 |
| Roy U, McMillan J, Alnouti Y, et al. (2012) Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1-infected human peripheral blood lymphocyte-reconstituted mice. The Journal of Infectious Diseases. 206: 1577-88 |
| Kanmogne GD, Singh S, Roy U, et al. (2012) Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells. International Journal of Nanomedicine. 7: 2373-88 |
| Balkundi S, Nowacek AS, Veerubhotla RS, et al. (2011) Comparative manufacture and cell-based delivery of antiretroviral nanoformulations. International Journal of Nanomedicine. 6: 3393-404 |
| Bressani RF, Nowacek AS, Singh S, et al. (2011) Pharmacotoxicology of monocyte-macrophage nanoformulated antiretroviral drug uptake and carriage. Nanotoxicology. 5: 592-605 |
| Nowacek AS, Balkundi S, McMillan J, et al. (2011) Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages. Journal of Controlled Release : Official Journal of the Controlled Release Society. 150: 204-11 |